PRECISION BIOSCIENCES INC
جودة البيانات: 100%
DTIL
NASDAQ
Manufacturing
Chemicals
KWD 7.53
▼
KWD 0.13
(-1.70%)
6 months return
—
Momentum
Neutral
5Y revenue growth
-26.20%
النمو
Revenue Growth (5Y)
-26.20%
أقل من متوسط القطاع (1.82%)
Revenue (1Y)-50.12%
Earnings (1Y)-737.98%
FCF Growth (3Y)N/A
الجودة
Return on Equity
-180.41%
أقل من متوسط القطاع (-54.47%)
ROIC-47.39%
Net Margin-133.45%
Op. Margin-152.19%
الأمان
Debt / Equity
N/A
Current Ratio3.45
Interest Coverage-36.67
التقييم
PE (TTM|NTM)
-3.65 | -2.25
أقل من متوسط القطاع (-1.50)
P/B Ratio10.04
EV/EBITDAN/A
Dividend YieldN/A
Quick Summary
Key Takeaways
Short bullets derived from reported financials—not the AI summary above.
Revenue declined -26.20% annually over 5 years
Earnings declined -737.98% over the past year
Negative free cash flow of -65.84 M
Revenue growth is decelerating — 1Y growth trails 5Y average by 23.92%
Price History
الاتجاهات المالية
السعر المستهدف للمحللين
4 محللين
Buy
+325.0%
upside to target
الحالي
KWD 7.53
Consensus Target
KWD 32.00
KWD 19.00
أدنى
KWD 60.00
أعلى
التوقعات
مكرر الربحية المستقبلي
-2.25
ربحية السهم المستقبلية
-KWD 3.40
الإيرادات المقدّرة
12.90 M
مفاجآت الأرباح
EPS
Reported
Estimate
Forecast
Next: Q1 2026
·
EPS Est: -KWD 0.80
·
Rev Est: 4.05 M
| Q12025 | Q22025 | Q32025 | Q42025 | Q1 '26 | Q2 '26 | |
|---|---|---|---|---|---|---|
| Reported | -KWD 2.21 | -KWD 2.13 | -KWD 1.84 | KWD 1.01 | — | — |
| Estimate | -KWD 2.42 | -KWD 2.21 | -KWD 2.21 | -KWD 0.64 | -KWD 0.80 | -KWD 0.92 |
| المفاجأة | +8.68% | +3.40% | +16.74% | +256.36% | — | — |
Growth
Rev 5Y: -26.20% · Earnings 1Y: -737.98%
Growth
Rev 5Y: -26.20% · Earnings 1Y: -737.98%| Revenue Growth (1Y) | -50.12% | Revenue Growth (3Y) | -16.14% |
| Earnings Growth (1Y) | -737.98% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -26.20% | Earnings Growth (5Y) | N/A |
Profitability
ROE: -180.41% · Net Margin: -133.45%
Profitability
ROE: -180.41% · Net Margin: -133.45%| Revenue (TTM) | 34.26 M | Net Income (TTM) | -45.72 M |
| ROE | -180.41% | ROA | -45.17% |
| Gross Margin | N/A | Operating Margin | -152.19% |
| Net Margin | -133.45% | Free Cash Flow (TTM) | -65.84 M |
| ROIC | -47.39% | FCF Growth (3Y) | N/A |
Safety
D/E: N/A · Current: 3.45
Safety
D/E: N/A · Current: 3.45| Debt / Equity | N/A | Current Ratio | 3.45 |
| Interest Coverage | -36.67 | Asset Turnover | 0.34 |
| Working Capital | 36.71 M | Tangible Book Value | 15.65 M |
Dividends
Yield: N/A · Payout: N/A
Dividends
Yield: N/A · Payout: N/A| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
Valuation
P/E: -3.65 · EV/EBITDA: N/A
Valuation
P/E: -3.65 · EV/EBITDA: N/A| P/E Ratio | -3.65 | Forward P/E | -2.25 |
| P/B Ratio | 10.04 | P/S Ratio | 4.87 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | 12.94 | Fwd Earnings Yield | N/A |
| FCF Yield | -39.44% | ||
| Market Cap | 166.95 M | Enterprise Value | 122.08 M |
Per Share
EPS: -3.56 · FCF/Share: -2.55
Per Share
EPS: -3.56 · FCF/Share: -2.55| EPS (Diluted TTM) | -3.56 | Revenue / Share | 1.33 |
| FCF / Share | -2.55 | OCF / Share | -2.55 |
| EPS CAGR (1Y) | -442.31% | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
Efficiency
FCF Conv: 144.00% · CapEx/Rev: N/A
Efficiency
FCF Conv: 144.00% · CapEx/Rev: N/A| CapEx / Revenue | N/A | FCF Conversion | 144.00% |
| SBC-Adj. FCF | -77.19 M | Growth Momentum | -23.92 |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 34.26 M | 68.70 M | 48.73 M | 25.10 M | 115.53 M |
| Net Income | -45.72 M | 7.17 M | -61.32 M | -111.64 M | -30.60 M |
| EPS (Diluted) | -3.56 | 1.04 | -15.96 | -1.27 | — |
| Gross Profit | — | — | — | — | — |
| Operating Income | -52.15 M | -26.16 M | -43.74 M | -100.37 M | -39.40 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 54.17 M | 59.56 M | 53.38 M | 83.94 M | 115.24 M |
| SG&A Expenses | — | — | — | — | — |
| D&A | 1.47 M | 3.40 M | 6.82 M | 7.80 M | 8.98 M |
| Interest Expense | 1.42 M | 1.78 M | 2.23 M | 1.11 M | 132,000.0 |
| Income Tax | 0.0 | — | — | — | 23,000.0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 154.42 M | 136.39 M | 159.78 M | 238.17 M | 211.50 M |
| Total Liabilities | 62.17 M | 80.00 M | 140.92 M | 177.74 M | 120.33 M |
| Shareholders' Equity | 92.25 M | 56.39 M | 18.86 M | 60.43 M | 91.17 M |
| Total Debt | — | — | 22.22 M | 22.22 M | 2.48 M |
| Cash & Equivalents | 110.82 M | 85.90 M | 116.68 M | 189.58 M | 143.66 M |
| Current Assets | 118.74 M | 94.99 M | 136.36 M | 199.11 M | 161.75 M |
| Current Liabilities | 8.91 M | 14.98 M | 49.99 M | 59.66 M | 35.98 M |
مقارنة الأقران
مقابل وسيط قطاع Manufacturing (1605 نظير)
مقارنة بشركات مشابهة في Manufacturing
مقارنة الأقران
مقابل وسيط قطاع Manufacturing (1605 نظير) مقارنة بشركات مشابهة في Manufacturing| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | -3.7 | -1.5 |
| P/B | 10.0 | 1.6 |
| ROE % | -180.4 | -54.5 |
| Net Margin % | -133.5 | -41.5 |
| Rev Growth 5Y % | -26.2 | 1.8 |
| D/E | — | 0.3 |
{"event":"ticker_viewed","properties":{"ticker":"DTIL","listing_kind":"stock","pathname":"/stocks/dtil","exchange":"NASDAQ","country":"US"}}